The global reproductive medicine sector, clinical embryology networks, specialized fertility delivery systems, and cryogenic bio-banking infrastructures are managing a major operational evolution centered on high-resolution blastocyst optimization, non-invasive genetic vetting, and expanded global demographic access. Assisted Reproductive Technology (ART)—encompassing medical procedures...